Acrux (ASX:ACR) Other Net Income (Loss) : A$0.00 Mil (TTM As of Dec. 2024)

View and export this data going back to 2004. Start your Free Trial

What is Acrux Other Net Income (Loss)?

Acrux's Other Net Income (Loss) for the six months ended in Dec. 2024 was A$0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 was A$0.00 Mil.

Acrux's quarterly Other Net Income (Loss) declined from Dec. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil) but then stayed the same from Jun. 2024 (A$0.00 Mil) to Dec. 2024 (A$0.00 Mil).

Acrux's annual Other Net Income (Loss) declined from Jun. 2022 (A$0.00 Mil) to Jun. 2023 (A$0.00 Mil) but then stayed the same from Jun. 2023 (A$0.00 Mil) to Jun. 2024 (A$0.00 Mil).

Acrux Other Net Income (Loss) Historical Data

The historical data trend for Acrux's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acrux Other Net Income (Loss) Chart

Acrux Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Other Net Income (Loss)

Get a 7-Day Free Trial

Acrux Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Acrux Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.00 Mil.

Acrux Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Acrux's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Acrux Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acrux Ltd (ASX:ACR) » Definitions » Other Net Income (Loss)

Comparable Companies

Traded in Other Exchanges

ARUXF:USA FJY:Germany

Address

103-113 Stanley Street, West Melbourne, Melbourne, VIC, AUS, 3003

Website

https://www.acrux.com.au

Acrux Ltd is a pharmaceutical company dedicated to developing and commercializing generic transdermal and topical prescription pharmaceuticals. The group is formulating and developing a range of topical generic products by leveraging its skilled workforce, on-site laboratories, GMP manufacturing suite, and technical, clinical, and commercial experience to bring affordable products to market. Geographically, it has a presence in Australia; the United States; Europe, and other countries. The firm operates in a single segment and derives revenue from developing and commercializing pharmaceutical products that administer drugs topically. Its product pipeline products include Lenzetto, Evamist, Testosterone Topical Solution, and among others.